Login

Kitamoto, Tetsuyuki

Prions

Kitamoto, Tetsuyuki - Prions, ebook

78,10€

Ebook, PDF with Adobe DRM
ISBN: 9784431294023
DRM Restrictions

PrintingNot allowed
Copy to clipboardNot allowed

Table of contents

1. Pathology of Variant Creutzfeldt-Jakob Disease
James W. Ironside

2. Clinical Aspects of Variant CJD
Richard Knight

3. Dura mater related Creutzfeldt-Jakob disease in Japan: Relationship between sites of grafts and clinical features
T. Sato, M. Masuda, Y. Utsumi, Y. Enomoto, M. Yamada, H. Mizusawa, T. Kitamoto

4. Treatment Options in Patients with Prion Disease - the Role of Long Term Cerebroventricular Infusion of Pentosan Polysulphate
Nikolai G. Rainov, Ian R. Whittle, Katsumi Doh-ura

5. Human prion diseases: novel diagnostic principles
Markus Glatzel

6. History and state of the art of PrP-res “typing” in Creutzfeldt-Jakob disease
Piero Parchi, Silvio Notari, Rosaria Strammiello, Sabina Capellari

7. Chronic Wasting Disease in Cervids in North America
Elizabeth S. Williams

8. Bovine spongiform encephalopathy (BSE) in Japan
Takashi Yokoyama, Kumiko M. Kimura, Morikazu Shinagawa

9. The role of host PrP in control of incubation time
Jean Manson, Rona Barron, Patricia Hart, Nadia Tuzi, Matthew Bishop

10. The role of the immune system in TSE agent neuroinvasion
Neil A. Mabbott, Joanne Mohan, Moira E. Bruce

11. Prion protein interactions and TSE infections in cell culture models
Gerald S. Baron

12. Semi-classical Quantization of Protein Dynamics: Novel NMR Relaxation Formalism and its Application to Prion
Kazuo Kuwata

13. Surveillance of chronic wasting disease (CWD) in Japan
Kimi Shimada, Yoshifumi Iwamaru, Hiroko Hayashi, Morikazu Imamura, Masuhiro Takata, Yuko K. Ushiki, Kumiko M. Kimura, Yuichi Tagawa, Motohiro Horiuchi, Morikazu Shinagawa, Takashi Yokoyama

14. Unexpected high incidence of visceral AA-amyloidosis in slaughtered cattle in Japan
Kana Tojo, Takahiko Tokuda, Yoshinobu Hoshii, Xiaoying Fu, Keiichi Higuchi, Takamine Matsui, Shu-ichi Ikeda

15. A Novel BSE screening kit with simplified preparation method for EIA
Takuji Yamamoto, Yuko Ushiki, William W. Hall, Shunji Hattori, Hiroe Tsukagoshi-Nagai, Takashi Yokoyama, Yuichi Tagawa, Tetsutaro Sata, Yoshio Yamakawa, Noriaki Kinoshita, Shinkichi Irie

16. Detection of recombinant bovine prion protein by fluorescence correlation spectroscopy
Fumihiko Fujii, Hiroshi Sakata, Masayoshi Ueno, Takayuki Yanagiya, Mamoru Tamura, Masataka Kinjo

17. PrPSc distribution of a natural case of bovine spongiform encephalopathy
Yoshifumi Iwamaru, Yuka Okubo, Tamako Ikeda, Hiroko Hayashi, Morikazu Imamura, Takashi Yokoyama, Morikazu Shinagawa

18. Report of the first oral inoculation of BSE prion into cattle in Japan
Ryoko Irie, Hiroyuki Okada, Hiroko Hayashi, Yoshifumi Iwamaru, Takashi Yokoyama, Morikazu Shinagawa

19. The development of the intracerebral inoculation method and BSE experimental transmissions to calves
Shigeo Fukuda, Satoshi Nikaido, Yoshitaka Matsui, Soichi Kageyama, Sadao Onoe

20. Comparative analyses of three mouse-adapted scrapie strains G1, Obihiro, and I3/I5 and pathogenesis of G1 strain-induced polyuria in ICR mice
Motohiro Horiuchi, Yu-koh Tamura, Hidefumi Furuoka

21. Dose effect on detection of PrPSc in follicular dendritic cells of knock-in mice for rapid bioassay
Shirou Mohri, Masahiro Asano, Yukiko Ishikawa, Yuichi Matsuura, Yukitoki Fujita, Tetsuyuki Kitamoto

22. Cell surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation
Motohiro Horiuchi, Chan-Lan Kim, Michiko Ogino, Hidefumi Furuoka, Morikazu Shinagawa

23. Prion-conformation-specific human antibodies established from phage display library
Shuhei Hashiguchi, Mayumi Yamamoto, Syoh Kitamoto, Toshihiro Nakashima, Hitoki Yamanaka, Daisuke Ishibashi, Suehiro Sakaguchi, Shigeru Katamine, Yuji Ito, Kazuhisa Sugimura

24. Partial characterization of monoclonal antibodies which bind to disease-associated prion protein in immunoprecipitaion assay
Yuko K. Ushiki, Ryo Endo, Yoshihisa Shimizu, Yoshifumi Iwamaru, Takuji Yamamoto, Shunji Hattori, Shinkichi Irie, Takashi Yokoyama

25. Production and Characterization of Monoclonal Antibodies Specific for Prion Protein
Masanori Morita, Akimasa Ohmizu, Hideki Maeno, Takato Matsuo, Yoichi Ogata, Mitsuru Naiki, Shouji Suzuki, Isao Nakata

26. In vitro selection of anti-mouse prion protein RNA aptamers
Satoru Sekiya, Ken Noda, Penmetcha K. R. Kumar, Takashi Yokoyama, Satoshi Nishikawa

27. Detection of the Prion Protein in a Liquid Phase Capture Assay Using Magnetic Beads Coupled to Protein A
Wen-Chu Yang, Edward S. Yeung, Mary Jo Schmerr, Walter Bodemer

28. New pretreatment method for immunohistochemistry for abnormal prion protein
Kensuke Sasaki, Katsumi Doh-ura, Toru Iwaki

29. Cellular prion protein suppresses the apoptosis in a neuronal cell line established from type-1 prion protein gene-deficient mice
Keiichi Saeki, Takuya Nishimura, Akikazu Sakudo, Yoshitsugu Matsumoto, Takashi Onodera

30. Cellular prion protein suppressess the apoptotic cell death by mediating the intracellular H2O2 in primary culture and immortalized neuronal cells
Izuru Nakamura, Takuya Nishimura, Keiichi Saeki, Yoshitsugu Matsumoto, Takashi Onodera

31. Targeting of cytosolic PrPC via a novel 14-3-3-Tom 70-mitochondrial BCL-2 pathway induces mitochondrial apoptosis
Naomi S. Hachiya, Makiko Yamada, Kota Watanabe, Akiko Jozuka, Yoshimichi Kozuka, Yuji Sakasegawa, Kiyotoshi Kaneko

32. Microtubule-dependent intracellular trafficking of cellular prion protein
Naomi S. Hachiya, Kota Watanabe, Makiko Yamada, Yuji Sakasegawa, Kiyotoshi Kaneko

33. Hsp90 modifies the conformation of recombinant mouse prion protein in vitro
Yuji Sakasegawa, Naomi S. Hachiya, Kiyotoshi Kaneko

34. Purification and characterization of a novel ATP-dependent robust protein-unfoldase, Unfoldin
Naomi S. Hachiya, Makiko Yamada, Akiko Jozuka, Yoshimichi Kozuka, Yuji Sakasegawa, Kiyotoshi Kaneko

35. Nucleic acid and Prion protein interaction produces spherical amyloids which in vivo can function as coats of Spongiform Encephalopathy agent
P. K. Nandi, J -C. Nicole

36. Species barrier in yeast [PSI+] prion transmission
Hideyuki Hara, Toru Nakayashiki, Yoshikazu Nakamura

37. Molecular memory of [PSI+] prion strains in S. cerevisiae is dependent on the primary structure of the Sup35 prion domain
Colin G. Crist, Toru Nakayashiki, Hiroshi Kurahashi, Yoshikazu Nakamura

38. Expression of a splice variant of prion protein during hypoxia in human glioblastoma cell line T98G
Yutaka Kikuchi, Tomoshi Kakeya, Ayako Sakai, Haruo Matsuda, Takeshi Yamazaki, Ken-ichi Tanamoto, Kikuko Ikeda, Naoto Yamaguchi, Jun-ichi Sawada, Kosuke Takatori

39. PRNP promoter region polymorphism in Creutzfeldt-Jakob disease
Pawel P. Liberski, Jolanta Bratosiewicz-Wasik J, Anna Zielinska, Gerard H. Jansen, Tomasz J. Wasik

40. Tubulovesicular structures are consistently found in prion diseases including vCJD and FFI
Pawel P. Liberski, Nicolas Kopp, Jean-Jacque Hauw, Herbert Budka

41. Autophagy is a common ultrastructural feature of neuropathology of prion diseases
Beata Sikorska, Pawel P. Liberski, Pierrie Giraud, Nicolas Kopp, Paul Brown

42. Type 1 and type 2 human PrPSc have different aggregation sizes in methionine homozygotes with sporadic, iatrogenic and variant Creutzfeldt-Jakob disease
Atsushi Kobayashi, Sakae Satoh, James W. Ironside, Shirou Mohri, Tetsuyuki Kitamoto

43. A pitfall in diagnosis of human prion diseases using detection of protease-resistant prion protein in urine: contamination with bacterial outer membrane proteins
Hisako Furukawa, Katsumi Doh-ura, Ryo Okuwaki, Susumu Shirabe, Kazuo Yamamoto, Heiichiro Udono, Takashi Ito, Shigeru Katamine, Masami Niwa

44. Comparative analysis of chronological data of total tau protein in CSF, serial studies of MRI (DWI, and FLAIR) and staging of clinical features in patients with sporadic CJD
Katsuya Satoh

45. Duration between initial manifestation of CJD and detection of PSD, specific findings on MRI, CSF 14-3-3 protein, or CSF high NSE
Nobuyuki Sodeyama, Yosikazu Nakamura, Masahito Yamada, Takeshi Satoh, Tetsuyuki Kitamoto, Hidehiro Mizusawa

46. Biochemical analysis of peripheral tissue involvement in transmissible spongiform encephalopathies
V. A. Lawson, A. F. Hill, V. Lewis, R. Sharpies, S. Collins, C. L. Masters

47. Involvement of the peripheral nervous system in human prion diseases including dural graft-associated Creutzfeldt-Jakob disease
Chiho Ishida, Soichi Okino, Tetsuyuki Kitamoto, Masahito Yamada

48. MM2 type sporadic Creutzfeldt-Jakob disease: clinicoradiologic features and clinical diagnosis
Tsuyoshi Hamaguchi, Tetsuyuki Kitamoto, Takeshi Sato, Hidehiro Mizusawa, Yosikazu Nakamura, Moeko Noguchi, Yutaka Furukawa, Chiho Ishida, Ichiei Kuji, Kazuko Mitani, Shigeo Murayama, Tatsuo Kohriyama, Sadao Katayama, Mariko Yamashita, Toru Yamarnoto, Fukashi Udaka, Akio Kawakami, Yuetsu Ihara, Tetsuya Nishinaka, Shigetoshi Kuroda, Naoki Suzuki, Yusei Shiga, Hiroyuki Arai, Masahiro Maruyama, Masahito Yamada

49. Early clinical and radiological diagnosis of sporadic Creuzfeldt-Jakob’s disease (sCJD) — a case study of pathologically-proved sCJD MV2 —
Kenji Ishihara, Masayuki Sugie, Jun-ichi Shiota, Mitsuru Kawamura, Tetsuyuki Kitamoto, Imaharu Nakano

50. Familial Creutzfeldt-Jakob disease with a point mutation (Met to Arg) at codon 232: two different phenotypes
Yusei Shiga, Hideki Mizuno, Shohei Watanabe, Maki Tateyama, Ichiro Nakashima, Kazuo Fujihara, Tetsuyuki Kitamoto, Yasuto Itoyama

51. Familial Creutzfeldt-Jakob disease with five octapeptide repeat insert
Yuko Saito, Shigeo Murayama, Jun Shimizu, Masataka Hoshino, Masami Takatsu, Yasuko Komatzusaki, Seigo Nakano, Kunimasa Arima, Kensuke Sasaki, Kei Takahashi, Masamichi Hara, Yoshio Hirayasu, Masahito Yamada, Ichiro Kanazawa

52. A case of Creutzfeldt-Jakob disease with a novel insertion mutation and codon 219 Lysine/Lysine polymorphism in the prion protein gene
Y. Nishida, N. Sodeyama, Y. Toru, S. Toru, T. Kitamoto, H. Mizusawa

53. Inhibition of Prion Propagation in Scrapie-infected Cell Lines using Mouse Monoclonal Antibodies against Prion Protein
Kazuyoshi Miyamoto, Naoto Nakamura, Noriyuki Nishida, Takashi Yokoyama, Masayoshi Aosasa, Hiroyuki Horiuchi, Shuichi Furusawa, Haruo Matsuda

54. The inhibitory effect of the ScFv of an anti-prion protein antibody secreted from N2a58 cells on abnormal prion protein accumulation in scrapie-infected cells, ScN2a
Yoshihisa Shimizu, Yuko Kaku-Ushiki, Shigeo Fukuda, Morikazu Shinagawa, Takashi Yokoyama, Yuichi Tagawa

55. Mucosal immunogenicity of prion protein fused with heat-labile enterotoxin B subunit
Hitoki Yamanaka, Daisuke Ishibashi, Takao Tsuji, Suehiro Sakaguchi

56. Identification of drugs that enhance the stimulatory effect of PrP on the fibrinolytic system
Guido Epple, Gerhard Kettelgerdes, Ute Mueller, Reinhard Geßner, Michael Praus

57. Screening study of prion binding agents and their inhibitory effect on the conversion of prion protein
Naoko Iwanami, Ushio Sankawa, Takaomi C. Saido, Yoshio Yamakawa, Masahiro Nishijima, Kiyotoshi Kaneko

58. Can Forage Grasses inhibit Prion Replication?
Tomofumi Miyamoto, Rie Sadatomi, Hiroyuki Tanaka, Ryuichi Higuchi, Satoshi Kawatake, Katsumi Doh-ura

59. Inhibition of abnormal PrP formation by amyloid-imaging probes in vitro
Kensuke Ishikawa, Yukitsuka Kudo, Katsumi Doh-ura

60. Treatment with Anti-malaria Agents, Quinacrine and Quinine, for Creutzfeldt - Jakob disease patients
Yoshio Tsuboi, Fujio Fujiki, Atsushi Yamauchi, Katsumi Doh-ura, Yasufumi Kataoka, Tatsuo Yamada

61. Effect of oral administration of pentosan polysulfate for patients with Creutzfeldt-Jakob disease (CJD) and new design for low molecular-weight of pentosan polysulfate
Susumu Shirabe, Katsuya Satoh, Katsumi Eguchi, Masami Niwa, Noriyuki Nishida, Atsushi Yamauchi, Yasufumi Kataoka, Shigeru Katamine

DRM-restrictions

Printing: not available
Clipboard copying: not available

Keywords: MEDICAL / Public Health MED078000

Author(s)
Publisher
Springer
Publication year
2005
Language
en
Edition
1
Category
Medicine, Health Care, Mode
Format
Ebook
eISBN (PDF)
9784431294023

Similar titles